David P. Bonita, Director at Loxo Oncology, Inc. (LOXO), sold 250,000 shares at $82.50 ($20.6M) on 2017-12-08, disclosed to the SEC on 2017-12-12.
Open-market sale of $20.6M LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PRLD | BUY | 2023-05-24 | $10.0M | — | Filing → |
| TCDA | SELL | 2022-11-25 | $3.2M | — | Filing → |
| THRD | BUY | 2022-09-21 | $5.1M | — | Filing → |